Treatment of Depression in Acute Coronary Syndromes with Selective Serotonin Reuptake Inhibitors

被引：0
|
作者：
Joost P. van Melle
Peter de Jonge
Maarten P. van den Berg
Harm J. Pot
Dirk J. van Veldhuisen
机构：
[1] University Medical Center Groningen,Department of Cardiology, Thoraxcenter
[2] University of Groningen,Department of Internal Medicine and Psychiatry
[3] University Medical Center Groningen,Department of Psychiatry
[4] University of Groningen,undefined
[5] University Medical Center Groningen,undefined
[6] University of Groningen,undefined
来源：
Drugs | 2006年 / 66卷
关键词：
Acute Coronary Syndrome; Heart Rate Variability; Fluoxetine; Paroxetine; Sertraline;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Depression in patients with acute coronary syndromes (ACS) is common and associated with impaired cardiovascular prognosis in terms of cardiac mortality and new cardiovascular events. It remains unclear whether antidepressant treatment may reverse these effects. In this review, the literature is evaluated on (i) the antidepressant efficacy of selective serotonin reuptake inhibitors (SSRIs) for depression in patients with ACS; (ii) the pleiomorphic effects of SSRIs that may be associated with cardiovascular prognosis; and (iii) the effects of SSRIs on cardiovascular prognosis.
引用
收藏
页码：2095 / 2107
页数：12
相关论文
共 50 条
  • [31] Meta-Analysis of Selective Serotonin Reuptake Inhibitors in Patients With Depression and Coronary Heart Disease
    Pizzi, Carmine
    Rutjes, Anne Wilhelmina Saskia
    Costa, Grazia Maria
    Fontana, Fiorella
    Mezzetti, Andrea
    Manzoli, Lamberto
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (07) : 972 - 979
  • [32] Selective serotonin reuptake inhibitors in the treatment of premature ejaculation
    Wang Wei-fu
    Chang Le
    Minhas, Suks
    Ralph, David J.
    CHINESE MEDICAL JOURNAL, 2007, 120 (11) : 1000 - 1006
  • [33] Selective serotonin reuptake inhibitors for fibromyalgia syndrome
    Walitt, Brian
    Urrutia, Gerard
    Betina Nishishinya, Maria
    Cantrell, Sarah E.
    Haeuser, Winfried
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (06):
  • [34] Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy
    Sura Alwan
    Jan M. Friedman
    CNS Drugs, 2009, 23 : 493 - 509
  • [35] Interactions of Selective Serotonin Reuptake Inhibitors with β-Amyloid
    Tin, Gary
    Mohamed, Tarek
    Shakeri, Arash
    Pham, Amy Trinh
    Rao, Praveen P. N.
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (01): : 226 - 234
  • [36] Discontinuation Syndromes with Selective Serotonin Reuptake InhibitorsAre There Clinically Relevant Differences?
    James S. Olver
    Graham D. Burrows
    Trevor R. Norman
    CNS Drugs, 1999, 12 : 171 - 177
  • [37] Effects of selective serotonin reuptake inhibitors on endocrine system (Review)
    Ruiz-Santiago, Carolina
    Rodriguez-Pinacho, Carla Valeria
    Perez-Sanchez, Gilberto
    Acosta-Cruz, Erika
    BIOMEDICAL REPORTS, 2024, 21 (03)
  • [38] EVALUATION OF THE ANDROGENIC/ANTIANDROGENIC ACTIVITY OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS
    Pop, Anca
    Lupu, Diana
    Cherfan, Julien
    Kiss, Bela
    Loghin, Felicia
    FARMACIA, 2015, 63 (03) : 343 - 348
  • [39] Selective Serotonin Reuptake Inhibitors in Older PatientsA Tolerability Perspective
    Ursula Skerritt
    Richard Evans
    Stuart A. Montgomery
    Drugs & Aging, 1997, 10 : 209 - 218
  • [40] A review of the safety of selective serotonin reuptake inhibitors during pregnancy
    Goldstein, DJ
    Sundell, K
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1999, 14 (05) : 319 - 324
12345